Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Find out which rewards program is best suited for your lifestyle and spending habits. Maximize your value with our expert insights!
22,671 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Institutional holders control roughly 87% of Starbucks' float, and analysts expect further upside as comps improve an...
A fresh AI hardware rally lifts Super Micro Computer while Meta Platforms remains the core beneficiary of AI spend, e...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...
Meta Platforms is pursuing a bold $9 trillion valuation by 2031 even after a blistering market setback. The plan hing...
A contrarian pick in the under-$10 pile is showing improving margins and debt relief, even as investors overlook it. ...
Alphabet posts stronger-than-expected Q1 2026 results driven by its vertically integrated AI stack, reinforcing its r...
This analysis breaks down the Q4 2025 earnings transcript for quest resource (qrhc), highlighting revenue, margins, a...
A three-way push for space-based AI puts Elon Musk and Jeff Bezos in a high-stakes orbit with a rising rival coalitio...
Adobe has been down over past year, testing investors' patience. This guide breaks down the root causes, outlines act...